Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Randall

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Journal of Virology|November 21, 2008
Mechanism of mda-5 Inhibition by paramyxovirus V proteinsK S Childs, J Andrejeva, R E Randall, et al.
Journal of Virology|February 12, 2002
Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferonsJ Andrejeva, D F Young, S Goodbourn, et al.
Journal of Virology|November 13, 1999
The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradationL Didcock, D F Young, S Goodbourn, et al.
Journal of Virology|March 12, 1999
Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesisL Didcock, D F Young, S Goodbourn, et al.
Vaccine|September 1, 1993
Two-tag purification of recombinant proteins for the construction of solid matrix-antibody-antigen (SMAA) complexes as vaccinesR E Randall, T Hanke, D Young, et al.
The Journal of General Virology|September 12, 2024
Liquid-liquid phase inclusion bodies in acute and persistent parainfluenaza virus type 5 infectionsE B Wignall-Fleming, T S Carlos, R E Randall
Annals of Internal Medicine|September 1, 1972
Bismuth nephrotoxicityR E Randall, R J Osheroff, S Bakerman, et al.
Virology|March 12, 2002
Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistenceN Chatziandreou, D Young, J Andrejeva, et al.
Virology|July 21, 2007
Catalytic turnover of STAT1 allows PIV5 to dismantle the interferon-induced anti-viral state of cellsB L Precious, T S Carlos, S Goodbourn, et al.
Vaccine|March 1, 1994
Purification of antibody-antigen complexes containing recombinant SIV proteins: comparison of antigen and antibody-antigen complexes for immune primingR E Randall, D Young, T Hanke, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Journal of Virology|November 21, 2008
Mechanism of mda-5 Inhibition by paramyxovirus V proteinsK S Childs, J Andrejeva, R E Randall, et al.
Journal of Virology|February 12, 2002
Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferonsJ Andrejeva, D F Young, S Goodbourn, et al.
Journal of Virology|November 13, 1999
The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradationL Didcock, D F Young, S Goodbourn, et al.
Journal of Virology|March 12, 1999
Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesisL Didcock, D F Young, S Goodbourn, et al.
Vaccine|September 1, 1993
Two-tag purification of recombinant proteins for the construction of solid matrix-antibody-antigen (SMAA) complexes as vaccinesR E Randall, T Hanke, D Young, et al.
The Journal of General Virology|September 12, 2024
Liquid-liquid phase inclusion bodies in acute and persistent parainfluenaza virus type 5 infectionsE B Wignall-Fleming, T S Carlos, R E Randall
Annals of Internal Medicine|September 1, 1972
Bismuth nephrotoxicityR E Randall, R J Osheroff, S Bakerman, et al.
Virology|March 12, 2002
Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistenceN Chatziandreou, D Young, J Andrejeva, et al.
Virology|July 21, 2007
Catalytic turnover of STAT1 allows PIV5 to dismantle the interferon-induced anti-viral state of cellsB L Precious, T S Carlos, S Goodbourn, et al.
Vaccine|March 1, 1994
Purification of antibody-antigen complexes containing recombinant SIV proteins: comparison of antigen and antibody-antigen complexes for immune primingR E Randall, D Young, T Hanke, et al.
Pageof 9